
### [MONDO:0015708](http://purl.obolibrary.org/obo/MONDO_0015708)
**Label:** Immuno-osseous dysplasia

**Subclasses:** [MONDO:0009595](http://purl.obolibrary.org/obo/MONDO_0009595) (cartilage-hair hypoplasia), [MONDO:0009458](http://purl.obolibrary.org/obo/MONDO_0009458) (Schimke immuno-osseous dysplasia), [MONDO:0009601](http://purl.obolibrary.org/obo/MONDO_0009601) (metaphyseal dysplasia without hypotrichosis), 

**Mapped go classes:** [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0005662](http://purl.obolibrary.org/obo/GO_0005662) (DNA replication factor A complex), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0000278](http://purl.obolibrary.org/obo/GO_0000278) (mitotic cell cycle), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), 

**Class expressions from DL-Learner:**

- [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity) 62.50%
- [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis) 62.50%
- [GO:0010171](http://purl.obolibrary.org/obo/GO_0010171) (body morphogenesis) 62.50%
- [GO:0005662](http://purl.obolibrary.org/obo/GO_0005662) (DNA replication factor A complex) 62.50%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 62.50%
- [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) and [GO:0140097](http://purl.obolibrary.org/obo/GO_0140097) (catalytic activity, acting on DNA) 62.50%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0017111](http://purl.obolibrary.org/obo/GO_0017111) (nucleoside-triphosphatase activity) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%
- [GO:0016818](http://purl.obolibrary.org/obo/GO_0016818) (hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%
- [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%
- [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%
- [GO:0016462](http://purl.obolibrary.org/obo/GO_0016462) (pyrophosphatase activity) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity) and [GO:0097617](http://purl.obolibrary.org/obo/GO_0097617) (annealing activity) 62.50%


